Trial Profile
Phase 1-2, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of ATX-101 (Sodium Deoxycholate for Injection) for the Reduction of Subcutaneous Fat in the Submental Area
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Jan 2022
Price :
$35
*
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions
- Sponsors Kythera Biopharmaceuticals
- 17 Jun 2014 New trial record